[ILS-FR-26] Lunch Seminar 26: Valuable glaucoma medical treatment from tomorrow
- Apr 04 (Fri)
- 12:15 - 13:15
- Room 12 - Tokyo International Forum 5F G510
- Pfizer Japan Inc.
- Chair）Tetsuya Yamamoto
- The main treatment strategy for glaucoma is medical IOP reduction. Since there’re so many eyedrops, selection of them with full consideration of individual conditions is of utmost importance. We have invited two distinguished glaucoma specialists to discuss this particular issue. Dr. Makoto Aihara will speak on how to choose the first-line drug with special emphasis on adherence. Prof. Takeo Fukuchi will talk on the selection of second-line drugs and emphasize the importance of long-term visual outcome. The Chairman believes that this seminar is worthwhile for better understanding of the practical glaucoma management.